The role of Stat3 in glioblastoma multiforme

Journal of Clinical Neuroscience

Volumn 20, Issue 7, 2013, Pages 907-911

  Luwor, Rodney B ^a   Stylli, Stanley S ^a,b   Kaye, Andrew H ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

Glioblastoma multiforme; Signaling; Stat3; Therapy

Indexed keywords

5 CHLORO N2 [1 (5 FLUORO 2 PYRIMIDINYL)ETHYL] N4 (5 METHYL 1H PYRAZOL 3 YL) 2,4 PYRIMIDINEDIAMINE; ANTINEOPLASTIC AGENT; INTERLEUKIN 6; JSI 124; MESSENGER RNA; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; PACLITAXEL; STAT3 PROTEIN; TEMOZOLOMIDE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; CANCER CELL CULTURE; CANCER GRADING; CANCER INHIBITION; CANCER TISSUE; DRUG EFFICACY; GLIOBLASTOMA; HUMAN; NONHUMAN; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; TRANSLATION REGULATION;

ANIMALS; BRAIN NEOPLASMS; GLIOBLASTOMA; HUMANS; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR;

EID: 84879005716     PISSN: 09675868     EISSN: 15322653     Source Type: Journal    
DOI: 10.1016/j.jocn.2013.03.006     Document Type: Review

References (61)

1. F.G. Davis, S. Freels, and J. Grutsch Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on Surveillance, Epidemiology, and End Results (SEER) data, 1973-1991 J Neurosurg 88 1998 1 10
2. S.S. Stylli, S.T. I, and A.H. Kaye Prognostic significance of Tks5 expression in gliomas J Clin Neurosci 19 2012 436 442
3. M.L. Wong, A.H. Kaye, and C.M. Hovens Targeting malignant glioma survival signalling to improve clinical outcomes J Clin Neurosci 14 2007 301 308 (Pubitemid 46335778)
4. L. Cher, M.A. Rosenthal, and K.J. Drummond The use of chemotherapy in patients with gliomas: patterns of care in Victoria from 1998-2000 J Clin Neurosci 15 2008 398 401
5. R. Stupp, W.P. Mason, and M.J. van den Bent Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma N Engl J Med 352 2005 987 996 (Pubitemid 40349501)
6. W.K. Yung, R.E. Albright, and J. Olson A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse Br J Cancer 83 2000 588 593 (Pubitemid 30636298)
7. L.A. Stewart Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials Lancet 359 2002 1011 1018 (Pubitemid 34286538)
8. S.S. Stylli, M. Howes, and L. MacGregor Photodynamic therapy of brain tumours: evaluation of porphyrin uptake versus clinical outcome J Clin Neurosci 11 2004 584 596 (Pubitemid 38916966)
9. S.S. Stylli, and A.H. Kaye Photodynamic therapy of cerebral glioma - A review. Part I - A biological basis J Clin Neurosci 13 2006 615 625 (Pubitemid 44066804)
10. S.S. Stylli, and A.H. Kaye Photodynamic therapy of cerebral glioma - A review. Part II - Clinical studies J Clin Neurosci 13 2006 709 717 (Pubitemid 44354170)
11. S.S. Stylli, A.H. Kaye, and L. MacGregor Photodynamic therapy of high grade glioma - Long term survival J Clin Neurosci 12 2005 389 398 (Pubitemid 40745222)
12. B. Tran, and M.A. Rosenthal Survival comparison between glioblastoma multiforme and other incurable cancers J Clin Neurosci 17 2010 417 421
13. J.F. Bromberg, M.H. Wrzeszczynska, and G. Devgan Stat3 as an oncogene Cell 98 1999 295 303 (Pubitemid 29380565)
14. J.E. Darnell Jr., I.M. Kerr, and G.R. Stark Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins Science 264 1994 1415 1421 (Pubitemid 24217131)
15. F. Zammarchi, E. de Stanchina, and E. Bournazou Antitumorigenic potential of STAT3 alternative splicing modulation Proc Natl Acad Sci USA 108 2011 17779 17784
16. E.C. Brantley, and E.N. Benveniste Signal transducer and activator of transcription-3: a molecular hub for signaling pathways in gliomas Mol Cancer Res 6 2008 675 684
17. R. Catlett-Falcone, T.H. Landowski, and M.M. Oshiro Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells Immunity 10 1999 105 115 (Pubitemid 29077388)
18. J.R. Grandis, S.D. Drenning, and A. Chakraborty Requirement of Stat3 but not Stat1 activation for epidermal growth factor receptor- mediated cell growth In vitro J Clin Invest 102 1998 1385 1392 (Pubitemid 28467567)
19. P.M. Siegel, and J. Massague Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer Nat Rev Cancer 3 2003 807 821
20. M. Abou-Ghazal, D.S. Yang, and W. Qiao The incidence, correlation with tumor-infiltrating inflammation, and prognosis of phosphorylated STAT3 expression in human gliomas Clin Cancer Res 14 2008 8228 8235
21. S. Kohsaka, L. Wang, and K. Yachi STAT3 inhibition overcomes temozolomide resistance in glioblastoma by downregulating MGMT expression Mol Cancer Ther 11 2012 1289 1299
22. H.W. Lo, X. Cao, and H. Zhu Constitutively activated STAT3 frequently coexpresses with epidermal growth factor receptor in high-grade gliomas and targeting STAT3 sensitizes them to Iressa and alkylators Clin Cancer Res 14 2008 6042 6054
23. M. Mizoguchi, R.A. Betensky, and T.T. Batchelor Activation of STAT3, MAPK, and AKT in malignant astrocytic gliomas: correlation with EGFR status, tumor grade, and survival J Neuropathol Exp Neurol 65 2006 1181 1188 (Pubitemid 44885942)
24. S.O. Rahaman, P.C. Harbor, and O. Chernova Inhibition of constitutively active Stat3 suppresses proliferation and induces apoptosis in glioblastoma multiforme cells Oncogene 21 2002 8404 8413 (Pubitemid 36054883)
25. H. Wang, W. Zhang, and H.J. Huang Analysis of the activation status of Akt, NFkappaB, and Stat3 in human diffuse gliomas Lab Invest 84 2004 941 951 (Pubitemid 39025029)
26. E.C. Brantley, L.B. Nabors, and G.Y. Gillespie Loss of protein inhibitors of activated STAT-3 expression in glioblastoma multiforme tumors: implications for STAT-3 activation and gene expression Clin Cancer Res 14 2008 4694 4704
27. L.K. Schaefer, Z. Ren, and G.N. Fuller Constitutive activation of Stat3alpha in brain tumors: localization to tumor endothelial cells and activation by the endothelial tyrosine kinase receptor (VEGFR-2) Oncogene 21 2002 2058 2065 (Pubitemid 34270894)
28. J. Weissenberger, S. Loeffler, and A. Kappeler IL-6 is required for glioma development in a mouse model Oncogene 23 2004 3308 3316 (Pubitemid 38669820)
29. D.A. Solomon, J.S. Kim, and J.C. Cronin Mutational inactivation of PTPRD in glioblastoma multiforme and malignant melanoma Cancer Res 68 2008 10300 10306
30. S. Veeriah, C. Brennan, and S. Meng The tyrosine phosphatase PTPRD is a tumor suppressor that is frequently inactivated and mutated in glioblastoma and other human cancers Proc Natl Acad Sci USA 106 2009 9435 9440
31. C.Y. Chang, M.C. Li, and S.L. Liao Prognostic and clinical implication of IL-6 expression in glioblastoma multiforme J Clin Neurosci 12 2005 930 933
32. C. Rolhion, F. Penault-Llorca, and J.L. Kemeny Interleukin-6 overexpression as a marker of malignancy in human gliomas J Neurosurg 94 2001 97 101 (Pubitemid 32799478)
33. A. Sasaki, S. Ishiuchi, and T. Kanda Analysis of interleukin-6 gene expression in primary human gliomas, glioblastoma xenografts, and glioblastoma cell lines Brain Tumor Pathol 18 2001 13 21
34. A. Tchirkov, T. Khalil, and E. Chautard Interleukin-6 gene amplification and shortened survival in glioblastoma patients Br J Cancer 96 2007 474 476 (Pubitemid 46215219)
35. A. Tchirkov, C. Rolhion, and S. Bertrand IL-6 gene amplification and expression in human glioblastomas Br J Cancer 85 2001 518 522 (Pubitemid 32808274)
36. E. Van Meir, Y. Sawamura, and A.C. Diserens Human glioblastoma cells release interleukin 6 in vivo and in vitro Cancer Res 50 1990 6683 6688 (Pubitemid 20348800)
37. M. Kudo, H. Jono, and S. Shinriki Antitumor effect of humanized anti-interleukin-6 receptor antibody (tocilizumab) on glioma cell proliferation. Laboratory investigation J Neurosurg 111 2009 219 225
38. A. Dasgupta, B. Raychaudhuri, and T. Haqqi Stat3 activation is required for the growth of U87 cell-derived tumours in mice Eur J Cancer 45 2009 677 684
39. L. Konnikova, M. Kotecki, and M.M. Kruger Knockdown of STAT3 expression by RNAi induces apoptosis in astrocytoma cells BMC Cancer 3 2003 23
40. G.H. Li, H. Wei, and Z.T. Chen STAT3 silencing with lentivirus inhibits growth and induces apoptosis and differentiation of U251 cells J Neurooncol 91 2009 165 174
41. Y. Xu, X. Li, and S. Zhang Targeting Stat3 suppresses growth of U251 cell-derived tumours in nude mice J Clin Neurosci 19 2012 443 446
42. M.M. Sherry, A. Reeves, and J.K. Wu STAT3 is required for proliferation and maintenance of multipotency in glioblastoma stem cells Stem cells 27 2009 2383 2392
43. Y.P. Yang, Y.L. Chang, and P.I. Huang Resveratrol suppresses tumorigenicity and enhances radiosensitivity in primary glioblastoma tumor initiating cells by inhibiting the STAT3 axis J Cell Physiol 227 2012 976 993
44. J. Liu, X. Xu, and X. Feng Adenovirus-mediated delivery of bFGF small interfering RNA reduces STAT3 phosphorylation and induces the depolarization of mitochondria and apoptosis in glioma cells U251 J Exp Clin Cancer Res 30 2011 80
45. J. Weissenberger, J.P. Steinbach, and G. Malin Development and malignant progression of astrocytomas in GFAP-v-src transgenic mice Oncogene 14 1997 2005 2013 (Pubitemid 27237002)
46. M.M. Inda, R. Bonavia, and A. Mukasa Tumor heterogeneity is an active process maintained by a mutant EGFR-induced cytokine circuit in glioblastoma Genes Dev 24 2010 1731 1745
47. H.K. Gan, A.H. Kaye, and R.B. Luwor The EGFRvIII variant in glioblastoma multiforme J Clin Neurosci 16 2009 748 754
48. B.D. Page, D.P. Ball, and P.T. Gunning Signal transducer and activator of transcription 3 inhibitors: a patent review Expert Opin Ther Pat 21 2011 65 83
49. C. Senft, M. Priester, and M. Polacin Inhibition of the JAK-2/STAT3 signaling pathway impedes the migratory and invasive potential of human glioblastoma cells J Neurooncol 101 2011 393 403
50. A. Iwamaru, S. Szymanski, and E. Iwado A novel inhibitor of the STAT3 pathway induces apoptosis in malignant glioma cells both in vitro and in vivo Oncogene 26 2007 2435 2444 (Pubitemid 46597261)
51. Y. Su, G. Li, and X. Zhang JSI-124 inhibits glioblastoma multiforme cell proliferation through G(2)/M cell cycle arrest and apoptosis augment Cancer Biol Ther 7 2008 1243 1249
52. Y. Ren, X. Zhou, and M. Mei MicroRNA-21 inhibitor sensitizes human glioblastoma cells U251 (PTEN-mutant) and LN229 (PTEN-wild type) to taxol BMC Cancer 10 2010 27
53. B.C. McFarland, J.Y. Ma, and C.P. Langford Therapeutic potential of AZD1480 for the treatment of human glioblastoma Mol Cancer Ther 10 2011 2384 2393
54. N. de la Iglesia, S.V. Puram, and A. Bonni STAT3 regulation of glioblastoma pathogenesis Curr Mol Med 9 2009 580 590
55. N. de la Iglesia, G. Konopka, and K.L. Lim Deregulation of a STAT3-interleukin 8 signaling pathway promotes human glioblastoma cell proliferation and invasiveness J Neurosci 28 2008 5870 5878
56. N. de la Iglesia, G. Konopka, and S.V. Puram Identification of a PTEN-regulated STAT3 brain tumor suppressor pathway Genes Dev 22 2008 449 462 (Pubitemid 351272753)
57. B. Desbuquois, N. Carre, and A.F. Burnol Regulation of insulin and type 1 insulin-like growth factor signaling and action by the Grb10/14 and SH2B1/B2 adaptor proteins FEBS J 280 2013 794 816
58. M.Z. Lin, K.A. Marzec, and J.L. Martin The role of insulin-like growth factor binding protein-3 in the breast cancer cell response to DNA-damaging agents Oncogene 2012 [Epub ahead of print]
59. R.B. Luwor, A.H. Kaye, and H.J. Zhu Transforming growth factor-beta (TGF-beta) and brain tumours J Clin Neurosci 15 2008 845 855
60. G. Choe, S. Horvath, and T.F. Cloughesy Analysis of the phosphatidylinositol 3′-kinase signaling pathway in glioblastoma patients in vivo Cancer Res 63 2003 2742 2746 (Pubitemid 36667143)
61. I.K. Mellinghoff, M.Y. Wang, and I. Vivanco Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors N Engl J Med 353 2005 2012 2024 (Pubitemid 41609094) Excellence